Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
29 Janeiro 2025 - 9:01PM
Edgar (US Regulatory)
EXHIBIT 99.1
JOINT ACQUISITION STATEMENT
PURSUANT TO RULE 13d-1(k)
The undersigned acknowledge
and agree that the foregoing statement on Schedule 13G is filed on behalf of each of the undersigned and that all subsequent amendments
to this statement on Schedule 13G shall be filed on behalf of each of the undersigned without the necessity of filing additional joint
filing agreements. The undersigned acknowledge that each shall be responsible for the timely filing of such amendments, and for the completeness
and accuracy of the information concerning him or it contained herein and therein, but shall not be responsible for the completeness and
accuracy of the information concerning the others, except to the extent that he or it knows or has reason to believe that such information
is inaccurate.
POINT72 ASSET MANAGEMENT, L.P. |
|
|
|
|
|
/s/ Jason M. Colombo |
|
Name: Jason M. Colombo |
|
Title: Authorized Person |
|
POINT72 CAPITAL ADVISORS, INC. |
|
|
|
|
|
/s/ Jason M. Colombo |
|
Name: Jason M. Colombo |
|
Title: Authorized Person |
|
STEVEN A. COHEN |
|
|
|
|
|
/s/ Jason M. Colombo |
|
Name: Jason M. Colombo |
|
Title: Authorized Person |
|
Aadi Bioscience (NASDAQ:AADI)
Gráfico Histórico do Ativo
De Jan 2025 até Fev 2025
Aadi Bioscience (NASDAQ:AADI)
Gráfico Histórico do Ativo
De Fev 2024 até Fev 2025